SEC Form 4 · accession 0001209191-17-036794
SOPHIRIS BIO INC. · SPHS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lars Ekman
Director
Period of report
May 30, 2017
Accepted (ET)
Jun 1, 2017 · 4:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001563855
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1,F2 | $2.44 | May 30, 2017 | A | 20,000 | A | Jun 30, 2017 | May 29, 2027 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1Granted pursuant to the Company's 2017 Non-Employee Director Compensation Program.
- F21/12th of the shares subject to this option shall vest and become exercisable monthly over a one year period.